TWI340139B - Organic compounds - Google Patents

Organic compounds

Info

Publication number: TWI340139B
Authority: TW; Taiwan
Prior art keywords: organic compounds; compounds; organic
Prior art date: 2003-05-02

Application number

TW093112339A

Other languages

English (en)

Other versions

TW200505920A (en

Inventor

Stephen Paul Collingwood

Brian Cox

Urs Baettig

Gurdip Bhalay

Nicholas James Devereux

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-05-02

Filing date

2004-04-30

Publication date

2011-04-11

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33420896&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TWI340139(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-10-24 Priority claimed from GB0324887A external-priority patent/GB0324887D0/en

2004-04-30 Application filed by Novartis Ag filed Critical Novartis Ag

2005-02-16 Publication of TW200505920A publication Critical patent/TW200505920A/zh

2011-04-11 Application granted granted Critical

2011-04-11 Publication of TWI340139B publication Critical patent/TWI340139B/zh

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Immunology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Otolaryngology (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Plural Heterocyclic Compounds (AREA)

TW093112339A 2003-05-02 2004-04-30 Organic compounds TWI340139B (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB0310232		2003-05-02
GB0324887A GB0324887D0 (en)	2003-10-24	2003-10-24	Organic compounds

Publications (2)

Publication Number	Publication Date
TW200505920A TW200505920A (en)	2005-02-16
TWI340139B true TWI340139B (en)	2011-04-11

Family

ID=33420896

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TW093112339A TWI340139B (en)	2003-05-02	2004-04-30	Organic compounds

Country Status (31)

Country	Link
US (2)	US20070060563A1 (zh)
EP (1)	EP1631569B1 (zh)
JP (1)	JP4416786B2 (zh)
KR (1)	KR100896544B1 (zh)
AR (1)	AR044134A1 (zh)
AT (1)	ATE440840T1 (zh)
AU (1)	AU2004234069B2 (zh)
BR (1)	BRPI0410238A (zh)
CA (1)	CA2523436C (zh)
CL (1)	CL2004000918A1 (zh)
CO (1)	CO5700782A2 (zh)
CY (1)	CY1109655T1 (zh)
DE (1)	DE602004022805D1 (zh)
DK (1)	DK1631569T3 (zh)
EC (1)	ECSP056134A (zh)
ES (1)	ES2331185T3 (zh)
HR (1)	HRP20050933A2 (zh)
IL (1)	IL171591A (zh)
IS (1)	IS2746B (zh)
MA (1)	MA27775A1 (zh)
MX (1)	MXPA05011739A (zh)
MY (1)	MY142652A (zh)
NO (1)	NO20055688L (zh)
NZ (1)	NZ542995A (zh)
PE (1)	PE20050465A1 (zh)
PL (1)	PL1631569T3 (zh)
PT (1)	PT1631569E (zh)
RU (1)	RU2363700C2 (zh)
SI (1)	SI1631569T1 (zh)
TW (1)	TWI340139B (zh)
WO (1)	WO2004096800A2 (zh)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2239546B1 (es) *	2004-03-15	2006-12-01	Almirall Prodesfarma, S.A.	Nuevos esteres de quinuclidina cuaternizados.
GB0410712D0 (en)	2004-05-13	2004-06-16	Novartis Ag	Organic compounds
GB0424284D0 (en)	2004-11-02	2004-12-01	Novartis Ag	Organic compounds
GB0428416D0 (en)	2004-12-24	2005-02-02	Novartis Ag	Organic compounds
GB0601951D0 (en)	2006-01-31	2006-03-15	Novartis Ag	Organic compounds
EP1900737A1 (en) *	2006-08-31	2008-03-19	Novartis AG	Polymorph of (R)-3-(2-hydroxy-2,2-diphenyl-acetoxy)-1-(isoxazol-3-ylcarbamoyl-methyl)-1-azonia-bicyclo-[2.2.2]octane bromide
EP1894568A1 (en) *	2006-08-31	2008-03-05	Novartis AG	Pharmaceutical compositions for the treatment of inflammatory or obstructive airway diseases
TW200825084A (en)	2006-11-14	2008-06-16	Astrazeneca Ab	New compounds 521
BRPI0721039A2 (pt) *	2006-12-19	2014-07-29	Astrazeneca Ab	" derivados de quinuclidinol como antagonistas de receptores muscarínicos ".
EP1950196A1 (de) *	2007-01-29	2008-07-30	Boehringer Ingelheim Pharma GmbH & Co. KG	Verfahren zur Herstellung von Ammoniumhexafluorophosphaten
BRPI0816219B8 (pt)	2007-09-07	2021-05-25	Theravance Biopharma R&D Ip Llc	compostos contendo guanidina úteis como antagonistas de receptor muscarínico, composição farmacêutica e uso
EP2222637A1 (en) *	2007-12-14	2010-09-01	Theravance, Inc.	Amidine-containing compounds useful as muscarinic receptor antagonists
JP5584138B2 (ja)	2008-01-11	2014-09-03	ノバルティスアーゲー	キナーゼ阻害剤としてのピリミジン類
KR20110010725A (ko) *	2008-05-13	2011-02-07	아스트라제네카 아베	무스카린성 수용체 길항제 및 β２아드레날린수용체 효능제를 포함하는 제약 생성물
EP2300464A1 (en) *	2008-05-13	2011-03-30	AstraZeneca AB	Quinuclidine derivatives as muscarinic m3 receptor antagonists
GB0808709D0 (en) *	2008-05-13	2008-06-18	Astrazeneca Ab	New combination 295
US20090326004A1 (en)	2008-06-03	2009-12-31	Ranbaxy Laboratories Limited	Muscarinic receptor antagonists
WO2009153536A1 (en) *	2008-06-17	2009-12-23	Argenta Discovery Limited	1-aza-bicyclo [2.2.2] octane derivatives useful as muscarinic receptor antagonists
GB0811100D0 (en) *	2008-06-17	2008-07-23	Astrazeneca Ab	New combination
BR112012032332A2 (pt) *	2010-06-22	2016-11-08	Chiesi Farma Spa	composto, uso de um composto, composição farmacêutica, combinação de um composto e dispositivo
UY33597A (es)	2010-09-09	2012-04-30	Irm Llc	Compuestos y composiciones como inhibidores de la trk
WO2012034095A1 (en)	2010-09-09	2012-03-15	Irm Llc	Compounds and compositions as trk inhibitors
GEP20156285B (en)	2011-02-25	2015-05-11	Aierem Elelsi	Compounds and compositions as trk inhibitors
JP2011195593A (ja) *	2011-06-30	2011-10-06	Astrazeneca Ab	ムスカリンｍ３受容体アンタゴニストとしてのキヌクリジン誘導体
CA2862008A1 (en) *	2011-12-30	2013-07-04	Chiesi Farmaceutici S.P.A.	Quinuclidine esters of 1-azaheterocyclylacetic acid as antimuscarinic agents, process for their preparation and medicinal compositions thereof
US9687488B2 (en)	2012-05-03	2017-06-27	St. Louis College Of Pharmacy	Compositions and methods for increasing neurotrophic peptides
TWI647227B (zh)	2013-02-28	2019-01-11	日商安斯泰來製藥股份有限公司	２－醯胺噻唑衍生物或其鹽
CZ306791B6 (cs)	2013-10-29	2017-07-12	Zentiva, K.S.	Průmyslově využitelný způsob přípravy aklidinium bromidu o vysoké čistotě
PT108370B (pt) *	2015-03-30	2018-10-25	Hovione Farm S A	Processo de preparação de brometo de aclidínio
ES2897697T3 (es)	2015-07-03	2022-03-02	Novartis Ag	Inhalador adaptado para leer información almacenada en un medio de almacenamiento de datos de un recipiente

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1219606A (en) *	1968-07-15	1971-01-20	Rech S Et D Applic Scient Soge	Quinuclidinol derivatives and preparation thereof
DK534178A (da) *	1977-12-16	1979-06-17	Interx Research Corp	Anticholinerge midler med sektrtionshaemmende virkning
IT1230881B (it) *	1989-06-20	1991-11-08	Angeli Inst Spa	Derivati del r(-) 3-chinuclidinolo
ES2165768B1 (es) *	1999-07-14	2003-04-01	Almirall Prodesfarma Sa	Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
CA2415468A1 (en) *	2000-07-11	2003-01-10	Yoshio Ogino	Ester derivatives
PT1353919E (pt) *	2000-12-28	2006-11-30	Almirall Prodesfarma Ag	Novos derivados de quinuclidina e composições medicinais contendo os mesmos
WO2003053966A2 (en) *	2001-12-20	2003-07-03	Laboratorios S.A.L.V.A.T., S.A.	1-alkyl-1-azoniabicyclo [2.2.2] octane carbamate derivatives and their use as muscarinic receptor antagonists
GB0424284D0 (en)	2004-11-02	2004-12-01	Novartis Ag	Organic compounds
EP1900737A1 (en) *	2006-08-31	2008-03-19	Novartis AG	Polymorph of (R)-3-(2-hydroxy-2,2-diphenyl-acetoxy)-1-(isoxazol-3-ylcarbamoyl-methyl)-1-azonia-bicyclo-[2.2.2]octane bromide

2004
- 2004-04-29 AR ARP040101468A patent/AR044134A1/es not_active Application Discontinuation
- 2004-04-30 CA CA2523436A patent/CA2523436C/en not_active Expired - Fee Related
- 2004-04-30 CL CL200400918A patent/CL2004000918A1/es unknown
- 2004-04-30 JP JP2006505341A patent/JP4416786B2/ja not_active Expired - Fee Related
- 2004-04-30 TW TW093112339A patent/TWI340139B/zh not_active IP Right Cessation
- 2004-04-30 HR HR20050933A patent/HRP20050933A2/xx not_active Application Discontinuation
- 2004-04-30 SI SI200431277T patent/SI1631569T1/sl unknown
- 2004-04-30 MY MYPI20041637A patent/MY142652A/en unknown
- 2004-04-30 PL PL04730519T patent/PL1631569T3/pl unknown
- 2004-04-30 WO PCT/EP2004/004605 patent/WO2004096800A2/en not_active Ceased
- 2004-04-30 NZ NZ542995A patent/NZ542995A/en not_active IP Right Cessation
- 2004-04-30 KR KR1020057020776A patent/KR100896544B1/ko not_active Expired - Fee Related
- 2004-04-30 AU AU2004234069A patent/AU2004234069B2/en not_active Ceased
- 2004-04-30 PE PE2004000435A patent/PE20050465A1/es not_active Application Discontinuation
- 2004-04-30 ES ES04730519T patent/ES2331185T3/es not_active Expired - Lifetime
- 2004-04-30 BR BRPI0410238-0A patent/BRPI0410238A/pt not_active IP Right Cessation
- 2004-04-30 DE DE602004022805T patent/DE602004022805D1/de not_active Expired - Lifetime
- 2004-04-30 PT PT04730519T patent/PT1631569E/pt unknown
- 2004-04-30 AT AT04730519T patent/ATE440840T1/de active
- 2004-04-30 US US10/554,558 patent/US20070060563A1/en not_active Abandoned
- 2004-04-30 RU RU2005137360/04A patent/RU2363700C2/ru not_active IP Right Cessation
- 2004-04-30 EP EP04730519A patent/EP1631569B1/en not_active Expired - Lifetime
- 2004-04-30 DK DK04730519T patent/DK1631569T3/da active
- 2004-04-30 MX MXPA05011739A patent/MXPA05011739A/es active IP Right Grant
2005
- 2005-10-27 IL IL171591A patent/IL171591A/en not_active IP Right Cessation
- 2005-11-01 EC EC2005006134A patent/ECSP056134A/es unknown
- 2005-11-03 CO CO05112195A patent/CO5700782A2/es not_active Application Discontinuation
- 2005-11-08 MA MA28583A patent/MA27775A1/fr unknown
- 2005-11-30 IS IS8158A patent/IS2746B/is unknown
- 2005-12-01 NO NO20055688A patent/NO20055688L/no not_active Application Discontinuation
2009
- 2009-10-20 US US12/582,291 patent/US8168654B2/en not_active Expired - Fee Related
- 2009-11-25 CY CY20091101230T patent/CY1109655T1/el unknown

Also Published As

Publication number	Publication date
AR044134A1 (es)	2005-08-24
BRPI0410238A (pt)	2006-05-16
CA2523436C (en)	2011-11-01
MY142652A (en)	2010-12-15
EP1631569B1 (en)	2009-08-26
WO2004096800A3 (en)	2005-01-06
SI1631569T1 (sl)	2010-01-29
EP1631569A2 (en)	2006-03-08
NZ542995A (en)	2009-02-28
MA27775A1 (fr)	2006-02-01
KR20060015572A (ko)	2006-02-17
AU2004234069B2 (en)	2008-02-21
KR100896544B1 (ko)	2009-05-07
IL171591A (en)	2010-11-30
DK1631569T3 (da)	2009-11-23
PE20050465A1 (es)	2005-07-18
TW200505920A (en)	2005-02-16
JP2006525267A (ja)	2006-11-09
US20100041887A1 (en)	2010-02-18
US20070060563A1 (en)	2007-03-15
RU2363700C2 (ru)	2009-08-10
IS8158A (is)	2005-11-30
ECSP056134A (es)	2006-04-19
NO20055688L (no)	2006-01-09
JP4416786B2 (ja)	2010-02-17
RU2005137360A (ru)	2006-07-27
NO20055688D0 (no)	2005-12-01
HK1087704A1 (zh)	2006-10-20
IS2746B (is)	2011-08-15
US8168654B2 (en)	2012-05-01
ES2331185T3 (es)	2009-12-23
CA2523436A1 (en)	2004-11-11
CL2004000918A1 (es)	2005-02-11
ATE440840T1 (de)	2009-09-15
DE602004022805D1 (de)	2009-10-08
WO2004096800A2 (en)	2004-11-11
AU2004234069A1 (en)	2004-11-11
CO5700782A2 (es)	2006-11-30
CY1109655T1 (el)	2014-08-13
PT1631569E (pt)	2009-11-26
MXPA05011739A (es)	2006-01-26
HRP20050933A2 (en)	2006-12-31
PL1631569T3 (pl)	2010-02-26

Publication	Publication Date	Title
GB0414440D0 (en)	2004-07-28	Organic compounds
TWI340139B (en)	2011-04-11	Organic compounds
GB0301259D0 (en)	2003-02-19	Organic compounds
GB0308335D0 (en)	2003-05-14	Organic compounds
GB0303503D0 (en)	2003-03-19	Organic compounds
GB0302876D0 (en)	2003-03-12	Organic compounds
GB0322612D0 (en)	2003-10-29	Organic compounds
GB0325175D0 (en)	2003-12-03	Organic compounds
GB0300095D0 (en)	2003-02-05	Organic compounds
GB0302748D0 (en)	2003-03-12	Organic compounds
GB0301471D0 (en)	2003-02-19	Organic compounds
GB0301938D0 (en)	2003-02-26	Organic compounds
GB0303506D0 (en)	2003-03-19	Organic compounds
GB0310868D0 (en)	2003-06-18	Organic compounds
GB0302991D0 (en)	2003-03-12	Organic compounds
GB0302874D0 (en)	2003-03-12	Organic compounds
GB0301561D0 (en)	2003-02-26	Organic compounds
GB0304641D0 (en)	2003-04-02	Organic compounds
GB0321712D0 (en)	2003-10-15	Organic compounds
GB0303323D0 (en)	2003-03-19	Organic compounds
GB0303321D0 (en)	2003-03-19	Organic compounds
GB0304642D0 (en)	2003-04-02	Organic compounds
GB0304713D0 (en)	2003-04-02	Organic compounds
GB0301470D0 (en)	2003-02-19	Organic compounds
GB0302749D0 (en)	2003-03-12	Organic compounds

Legal Events

Date	Code	Title	Description
2013-01-11	MM4A	Annulment or lapse of patent due to non-payment of fees